• BioCryst Pharmaceuticals Inc

4505 Emperor Boulevard
Durham, NC 27703
United States

Website Investor relation




Price

  • Last Close
  • $ 8.56 0 % -0.03
    Mar 29, 2023
  • Trading Volume
  • 2,567,977
  • 52-Week High/Low
  • $19.76 - $7.78

  • Market Cap Full
  • $ 1.3B
  • YTD
  • -25%
2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Q1 -17.8% 16% 36.5% -5% 0.9% -2.9% 32.7% -72.6% -25.7% 39.2%
Q2 - -34.9% 55.5% 4% -56.2% 24.3% -33.8% 0.4% 65.3% 20.5%
Q3 - 19.1% -7.2% 8% -20.1% 34.6% -5.8% 55.3% -23.6% -23.3%
Q4 - -8.9% -4.5% 116.6% 8.1% 10.7% -7.9% 43.5% -9.5% 24.3%
J F M A M J J A S O N D
2023 -8.1% -18.1% - - - - - - - - - -
2022 9.9% 7.9% -2.1% -42.9% 0.2% 13.6% 4.2% 27.8% -10.5% 6% 0.1% -14.1%
    2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013
    -25%-18%88%127%-59%64%-22%-39%-15%60%435%

Earnings

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012
Q1 -0.36 -0.24 -0.28 -0.26 0.19 0.31 0.21 -0.17 -0.09 -0.13
Q2 -0.24 -0.24 -0.34 -0.19 0.21 0.22 0.06 -0.23 -0.23 -0.25
Q3 -0.33 -0.26 -0.34 -0.28 0.18 0.16 0.20 -0.12 -0.14 -0.19
Q4 - -0.35 0.02 -0.25 0.20 0.06 0.25 -0.16 -0.09 -0.22
A -0.6

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume